Figure 1From: The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children TCS in Canadian participants over the entire grass pollen season in the pooled adult pediatric 2009 trials and the adult-pediatric 2012 trial. Back to article page